Catalyst Pharmaceutical CPRX Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's share buybacks?
- Catalyst Pharmaceutical (CPRX) reported share buybacks of $14.57M in Q1 2026.
- How has Catalyst Pharmaceutical's share buybacks changed year-over-year?
- Catalyst Pharmaceutical's share buybacks increased by 130.4% year-over-year, from $6.33M to $14.57M.
- What is the long-term trend for Catalyst Pharmaceutical's share buybacks?
- Over 2 years (2021 to 2025), Catalyst Pharmaceutical's share buybacks has grown at a 44.2% compound annual growth rate (CAGR), from $12.18M to $25.3M.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.